Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robak

Showing results (211-220 of 292) with videos related to

Pageof 30
Sort By:
Mediators of Inflammation|May 18, 2000
Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remissionT Robak, A Wierzbowska, M Błasińska-Morawiec, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1992
The influence of recombinant human tumor necrosis factor (rh-TNF alpha) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in cultures in vitroT Robak, A Korycka, J Góra-Tybor, et al.
Leukemia & Lymphoma|November 8, 2001
Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femurT Robak, M Kasznicki, J Bartkowiak, et al.
Leukemia & Lymphoma|May 30, 2001
Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosusT Robak, E Robak, J Bartkowiak, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 12, 1999
Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activityE Robak, A Sysa-Jedrzejewska, B Dziankowska, et al.
Mediators of Inflammation|January 1, 1996
Tumour necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6) and their soluble receptors (sTNF-alpha-Rp55 and slL-6R) serum levels in systemic lupus erythematodesE Robak, A Sysa-Jedrzejowska, T Robak, et al.
Cytobios|January 1, 1996
Effect of granulocyte-macrophage colony stimulating factor and granulocyte colony stimulating factor on prolactin and adrenocorticotropic hormone secretion in rats: dose- and time-response in vivo studiesJ Komorowski, K Zylińska, S Mucha, et al.
The British Journal of Dermatology|December 3, 1999
Disseminated superficial actinic porokeratosis in a patient with systemic lupus erythematosusE Robak, A Woźniacka, A Sysa-J&ecedil;drzejowska, et al.
European Journal of Haematology|May 15, 2001
Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignanciesT Robak, J Góra-Tybor, E Lech-Marańda, et al.
Advances in Medical Sciences|February 28, 2012
Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) - a single-center experienceA Wolska, T Robak, A Szmigielska-Kaplon, et al.
Pageof 30

Showing results (211-220 of 292) with videos related to

Sort By:
Pageof 30
Mediators of Inflammation|May 18, 2000
Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remissionT Robak, A Wierzbowska, M Błasińska-Morawiec, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1992
The influence of recombinant human tumor necrosis factor (rh-TNF alpha) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in cultures in vitroT Robak, A Korycka, J Góra-Tybor, et al.
Leukemia & Lymphoma|November 8, 2001
Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femurT Robak, M Kasznicki, J Bartkowiak, et al.
Leukemia & Lymphoma|May 30, 2001
Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosusT Robak, E Robak, J Bartkowiak, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 12, 1999
Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activityE Robak, A Sysa-Jedrzejewska, B Dziankowska, et al.
Mediators of Inflammation|January 1, 1996
Tumour necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6) and their soluble receptors (sTNF-alpha-Rp55 and slL-6R) serum levels in systemic lupus erythematodesE Robak, A Sysa-Jedrzejowska, T Robak, et al.
Cytobios|January 1, 1996
Effect of granulocyte-macrophage colony stimulating factor and granulocyte colony stimulating factor on prolactin and adrenocorticotropic hormone secretion in rats: dose- and time-response in vivo studiesJ Komorowski, K Zylińska, S Mucha, et al.
The British Journal of Dermatology|December 3, 1999
Disseminated superficial actinic porokeratosis in a patient with systemic lupus erythematosusE Robak, A Woźniacka, A Sysa-J&ecedil;drzejowska, et al.
European Journal of Haematology|May 15, 2001
Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignanciesT Robak, J Góra-Tybor, E Lech-Marańda, et al.
Advances in Medical Sciences|February 28, 2012
Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) - a single-center experienceA Wolska, T Robak, A Szmigielska-Kaplon, et al.
Pageof 30